Arizona Bioscience News: COVID-19 in Arizona; Dolphins help TGen study aging; UArizona develops technology for cataract patients

August 13, 2020

By Matt Ellsworth

While COVID-19 trends in Arizona continue to improve, a new report shows the state has the highest rate of children and young adults 19 and under testing positive for the infection. A number of late-stage clinical trials are underway in Arizona to test drugs for possible COVID-19 treatments while vaccine clinical trials continue as well. The COVID-19 pandemic could be having health impacts well beyond an infection. Banner Health reports a dramatic drop in cancer screenings and diagnoses as people are likely delaying care. 

Could one of these drugs be the next emergency treatment for COVID-19? / Arizona Republic

Arizona has highest rate of pediatric COVID-19 in the US, report says / Arizona Republic

New reports find Arizona at the top for kids testing positive for COVID-19 / 12 News

Improving Arizona COVID-19 trends could drive testing declines, complacency / KJZZ

COVID-19 cases are falling in Arizona, but risk level remains high / Arizona Daily Star

COVID-19 tests in Arizona dropped dramatically in July. Here’s why that’s an issue / Arizona Republic

Race for protection underway as coronavirus vaccine trials continue in Arizona / ABC 15

Pediatricians urge Arizona families not to skip childhood vaccines during COVID-19 / Arizona Republic

Arizona doctor: Cancer diagnoses down during COVID-19 pandemic /

Banner Health reports drop in cancer diagnoses during virus pandemic / KTAR

ASU, UA And NAU outline plans for fall reopening / KJZZ

TGen study of U.S. Navy dolphins offers clues to human aging / KJZZ

Researchers from the Translational Genomics Research Institute and partners have found biomarkers in dolphins that could help explain why some animals, including humans, age faster and develop more age-related diseases than others.

UA prof’s invention saving sight of cataract patients worldwide / Arizona Daily Star

Technology for a new kind of trifocal lens implant developed by a University of Arizona professor to help cataract patients see clearly has been used in more than 500,000 patients overseas and was approved for use in the U.S. last fall.

Sign up to receive Arizona Bioscience News weekly